Ascorbic acid 200mg tablets

Страна: Великобритания

Язык: английский

Источник: MHRA (Medicines & Healthcare Products Regulatory Agency)

Активный ингредиент:

Ascorbic acid

Доступна с:

Alliance Healthcare (Distribution) Ltd

код АТС:

A11GA01

ИНН (Международная Имя):

Ascorbic acid

дозировка:

200mg

Фармацевтическая форма:

Oral tablet

Администрация маршрут:

Oral

класс:

No Controlled Drug Status

Тип рецепта:

Valid as a prescribable product

Обзор продуктов:

BNF: 09060301

тонкая брошюра

Patient Information Lea
f
l
e
t A
S
C
O
R
B
I
C
A
C
I
D 20
0
M
G
T
AB
L
E
T
S
This medicine will be called Ascorbic Acid
T
a
b
l
e
t
s
in this
l
ea
f
l
e
t
.
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START
TAKING THIS MEDICINE.
• Keep this leaflet. You may need to read it again.
• This medicine is only for you. Do not give it to
anyone else to take. It may harm them, even if
their symptoms are the same as yours.
• If you have any further questions, please ask your
doctor or pharmacist.
• If you get any side effects talk to your doctor or
pharmacist. This includes any possible side effects
not listed in this leaflet. See section 4.
IN
THIS
L
E
A
FL
E
T
:
1. What Ascorbic Acid Tablets are and what they a
r
e
used
f
o
r
2. Before you take Ascorbic Acid
T
a
b
l
e
t
s
3. How to take Ascorbic Acid
T
a
b
l
e
t
s
4. Possible side e
ff
e
c
t
s
5. How to store Ascorbic Acid
T
a
b
l
e
t
s
6. Further
i
n
f
o
rm
a
t
io
n
1. WHAT ASCORBIC ACID
TABLETS
ARE
A
ND
WHAT THEY ARE USED
F
O
R
These tablets contain the active ingredient, a
s
c
o
r
b
i
c
acid. Ascorbic acid is the chemical name for
V
i
t
a
m
i
n
C. The tablets can be used to increase the amount
o
f
Vitamin C in the
d
i
e
t
.
Vitamin C Tablets are used to treat Vitamin C
deficiency including the prevention and treatment of
scurvy.
2. BEFORE YOU TAKE ASCORBIC ACID
TA
B
LE
T
S
SOME
PEOPLE
MUST NOT
TAKE THESE
T
A
B
L
E
T
S.
DO
NOT TAKE THESE TABLETS
IF
:
•
You know you are allergic to ascorbic acid or to any
of the other ingredients
(
t
h
e
s
e are listed in Section 6
)
•
You suffer from hyperoxaluria
(
e
x
c
e
ss
oxalic acid
i
n
the
ur
i
n
e
)
.
YOU
MUST
BE
ESPECIALLY CAREFUL
IF
:
•
You are pregnant or
b
r
ea
s
t
f
ee
d
i
n
g
.
•
You have an intolerance to some sugars.
T
h
e
s
e
tablets contain lactose and
su
c
r
o
s
e.
If any of the conditions above apply to you,
p
l
ea
s
e
discuss your treatment with your doctor before
t
a
ki
n
g
this
m
e
d
i
c
i
n
e.
TAKING OTHER
M
E
DICINES
Ascorbic Acid Tablets can affect some
o
t
h
e
r
medicines you may be taking.

Характеристики продукта

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Ascorbic Acid 200mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 200mg of ascorbic acid.
Excipient(s) with known effect
Lactose monohydrate
For the full list of excipients, see section 6.1
3
PHARMACEUTICAL FORM
Tablet.
White to off-white convex tablets.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Prevention and treatment of scurvy
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Adults and children over 6 years: _
Prophylactic:
25 – 75 mg daily.
Therapeutic:
Not less than 250mg daily in divided doses. Maximum of
1000mg daily.
_Children under 6 years: _
This unit dosage form is unsuitable for children under 6 years.
_Elderly: _As for other adults. As the dietary intake of vitamin C may
be less in
the elderly, they have greater risk of presenting with vitamin C
deficiency.
Method of administration
For oral administration.
4.3
CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the excipients
listed in
section 6.1.
Ascorbic acid should not be given to patients with hyperoxaluria.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Increased intake of ascorbic acid over a prolonged period may result
in an
increased renal clearance of ascorbic acid, and deficiency may result
if the
intake is reduced or withdrawn rapidly (see section 4.8).
Interference with serological testing
Ascorbic acid may interfere with tests and assays for urinary glucose,
giving
false-negative results with methods utilising glucose oxidase with
indicator
(e.g. Labstix, Tes-Tape) and false-positive results with neocuproine
methods.
Estimation of uric acid by phosphotungstate or uricase with copper
reduction and
measurement of creatinine in non-deproteinised serum may also be
affected.
High doses of ascorbic acid may give false-negative readings in faecal
occult blood
tests.
Patients with rare hereditary problems of galactose intolerance, total
lactase
deficiency or glucose-galactose malabsorption should not take this
medicine.
4